Prominent Platelet Aggregation Devices Market Trend for 2025: Innovative Platelet Pooling Set In The Platelet Aggregation Devices Market

What Are the Projected Growth and Market Size Trends for the Platelet Aggregation Devices Market?
Over the past few years, there has been a remarkable growth in the market size of platelet aggregation devices. The market is estimated to expand from $0.83 billion in 2024 to $1.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 25.8%. The historic period growth is mainly due to factors such as the surging number of cardiovascular disease cases, a rise in bleeding disorder incidents, increased awareness of health diagnostic tools, a surge in surgical procedures, and enhanced diagnostic precision.

Expectations are high for considerable expansion of the platelet aggregation devices market in the coming years, with projections indicating a potential value of $2.59 billion in 2029, growing at a compound annual growth rate (CAGR) of 25.4%. Factors contributing to this anticipated growth include an increasing elderly population, a surge in demand for point-of-care testing, advancement in personalized medicine, enhancements in regulatory support and approval processes, along with an escalating prevalence of chronic diseases. Forecasts for this period also indicate substantial trends such as the incorporation of artificial intelligence in diagnostic procedures, the creation of portable platelet aggregation devices, stronger collaborations between biotech companies and healthcare providers, the rising significance of data analytics in the healthcare sector, and a shift towards home-based diagnostic techniques.

What Key Elements Are Boosting Growth in the Platelet Aggregation Devices Market?
The rise in the prevalence of target diseases is anticipated to propel the growth of the platelet aggregation devices market. Target diseases represent specific health conditions, like cancer, cardiovascular diseases, and diabetes, that command significant focus in terms of prevention, diagnosis, and treatment due to their substantial effects on public health. Platelet aggregation devices contribute to curbing the prevalence of these diseases by enabling early detection and efficient regulation of thrombotic risks, consequently averting complications such as heart attacks and strokes in susceptible groups. For instance, in February 2024, the International Agency for Research on Cancer (IARC), a France-based cancer specialized agency of the World Health Organization (WHO), revealed that there were roughly 20 million new cancer instances and 9.7 million deaths in 2022 worldwide. Forecasts indicate a 77% surge to over 35 million new instances by 2050, with lung cancer leading with 2.5 million new instances (12.4%), followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Hence, the escalating prevalence of target diseases is fuelling the expansion of the platelet aggregation devices market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp

Which Leading Companies Are Shaping the Growth of the Platelet Aggregation Devices Market?
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago

What Are the Major Trends Shaping the Platelet Aggregation Devices Market?
Leading enterprises within the platelet aggregation devices market are sharpening their emphasis on concocting advanced solutions by introducing groundbreaking products such as the initial platelet pooling set, designed to stabilize the platelet supply in the U.S. and fulfill the surging demands. The platelet pooling set, an exclusive medical device, is used during plateletpheresis processes to gather and amplify platelets from several donors into a single transfusion-therapy unit. For instance, in February 2023, TERUMO BCT INC., a corporation based in the U.S. providing cellular technology and blood components, proclaimed the IMUGARD WB Platelet Pooling Set's approval by the Food and Drug Administration (FDA), a Federal agency in the U.S. This approval paves way for extending shelf-life of platelets, FDA endorsement for seven-day storage, and facilitates platelet recovery from whole blood donations, thereby boosting adaptability and accessibility in the platelet aggregation devices market. The launch marks considerable technological progression by targeting the necessity for augmented platelet availability, effective supply management and bolstering the burdened U.S. platelet supply to cater to the growing demand in crucial medical procedures such as organ transplants and chemotherapy.

What Are the Key Segments of the Platelet Aggregation Devices Market?
The platelet aggregation devices market covered in this report is segmented -

1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users

Subsegments:
1) By Reagents: Platelet Aggregation Assay Reagents, Coagulation And Anticoagulation Reagents
2) By Systems: Platelet Aggregation Testing Systems, Automated Platelet Aggregation Systems
3) By Consumables And Accessories: Sample Collection Kits, Testing Plates And Cuvettes, Calibration Kits

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Which Region Dominates the Platelet Aggregation Devices Market?
North America was the largest region in the platelet aggregation devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Platelet Aggregation Devices Global Market Report?

- Market Size Analysis: Analyze the Platelet Aggregation Devices Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Platelet Aggregation Devices Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Platelet Aggregation Devices Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Platelet Aggregation Devices Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15896

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.